Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma

NCT04818372 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma
Lymphoma

Interventions

DRUG: CM313-Dose escalation
DRUG: CM313
DRUG: Dexamethasone
DRUG: Lenalidomide

Sponsor

Keymed Biosciences Co.Ltd